# Cancer Risk Concerns and Communication Gaps Regarding GLP-1 Medications

## TL;DR

This study examines what patients are saying online about cancer risks from GLP-1 medications and how much they're discussing these concerns with their doctors.

## Contribution

The study provides new insights into patient concerns and communication gaps about cancer risks related to GLP-1 medications.

## Key findings

- Patients frequently express cancer risk concerns about GLP-1 medications on social media.
- There is a notable gap in communication between patients and clinicians regarding these concerns.

## Abstract

This cross-sectional study analyzes social media posts to explore patient concerns and the extent of patient–clinician communication regarding cancer risks associated with glucagon-like peptide-1 (GLP-1) medications.